Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Ketavet (Veterinary)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 314Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NRx Pharmaceuticals Implements Expanded Access for NRX-100
    NRx Pharmaceuticals Implements Expanded Access for NRX-100

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139980/0/en/NRx-Pharmaceuticals-Inc-NASDAQ-NRXP-Announces-Expanded-Access-Policy-for-NRX-100-preservative-free-ketamine.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)
    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139203/0/en/PharmaTher-Provides-Corporate-Update-Following-FDA-Approval-of-Ketamine-KETARx.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    Silo Pharma's Alzheimer's Candidate SPC-14 Highlighted in Journal
    Silo Pharma's Alzheimer's Candidate SPC-14 Highlighted in Journal

    21 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/21/3137424/0/en/Silo-Pharma-s-Alzheimer-s-Candidate-SPC-14-Featured-in-Leading-Scientific-Peer-reviewed-Journal.html

    GLOBENEWSWIRE
    21 Aug 2025
    Share Share
    MIRA Pharma's Ketamir-2 Shows Efficacy in Neuropathic Pain
    MIRA Pharma's Ketamir-2 Shows Efficacy in Neuropathic Pain

    12 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-12/mira-pharmaceuticals-second-ketamir-2-manuscript-accepted-for-peer-reviewed-publication-demonstrati

    PHARMAWEB
    12 Aug 2025
    Share Share
    Enforcement Report - Week of July 9, 2025
    Enforcement Report - Week of July 9, 2025

    09 Jul 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-9-2025-1119.pdf

    FDA
    09 Jul 2025
    Share Share
    PharmaTher Confirms FDA Approval Goal of August 9th for Ketamine
    PharmaTher Confirms FDA Approval Goal of August 9th for Ketamine

    02 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/02/3109115/0/en/PharmaTher-Announces-Path-to-Ketamine-Commercialization-with-No-Planned-Financing-Confirms-FDA-Approval-Goal-Date-of-August-9th-2025-for-Ketamine.html

    GLOBENEWSWIRE
    02 Jul 2025
    Share Share